We know that
life science companies face a growing and constantly evolving array of legal, medical and technological issues and challenges.
Not exact matches
She's lined up a host of
face - to -
face meetings with the heads of some of the world's leading
life sciences and technology
companies.
In similar fashion, we have become one of the select firms capable of handling all manner of disputes
facing companies in certain industry sectors, including media & entertainment, healthcare and
life sciences, and technology, among others.
The April 2015 district court ruling concerning Warner Chilcott's Doryx ® was affirmed by the Third Circuit in September 2016, creating an important precedent, particularly in the
life sciences sector, for
companies facing these challenges globally.
Our reputation in environmental law is founded on an in depth understanding of the varied legal, technical and policy issues
facing our clients, cost - effective staffing of environmental matters, utilizing the resources of a diverse international firm and an intimate familiarity with the energy, technology, chemical, manufacturing and
life sciences companies we represent.
In a recent Viewpoint interview, Riley Doyle, CEO and Technical Lead at Desktop Genetics, a rapidly growing biotech software
company based in London, spoke to us about the challenge
faced by many new
life science startups: